BRIEF-Cancer Genetics Files For Non-Timely 10-Q With U.S. SEC

Nov 14 (Reuters) - Cancer Genetics Inc :

   * CANCER GENETICS - FILES FOR NON-TIMELY 10-Q WITH U.S. SEC

   * CANCER GENETICS - DELAY IS DUE PRIMARILY TO RECENT ASSET SALES OF CLINICAL BUSINESS & BIOPHARMA BUSINESS

   * CANCER GENETICS - DUE TO BIOPHARMA BUSINESS SALE, CO LOST NUMEROUS EMPLOYEES

   * CANCER GENETICS - PLANS TO FILE FORM 10-Q FOR QUARTER ENDED SEPT 30, 2019 WITH SEC AS SOON AS PRACTICABLE

Source: () Further company coverage:

((Reuters.Briefs@thomsonreuters.com;)